Facebook
Twitter
LinkedIn
Forward
Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium - December 6, 2024
In-Person and Virtual attendance options are available.
Presented by the Houston Methodist Dr. Mary and Ron Neal Cancer Center
In this session, we will explore the latest advancements in surgical techniques for early-stage hepatobiliary cancer. The presentations will cover innovative operative approaches that enhance surgical outcomes and improve patient recovery. Expert surgeons will discuss their experiences with new technologies and methods, including minimally invasive procedures and enhanced imaging techniques. Key trends and recent studies will be reviewed to highlight how these advancements contribute to better management of hepatobiliary cancers.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Houston Methodist Employees | Complimentary |
| Physician (Private physician located within the Greater Houston Area)* | $185 |
| Physician (Private physician located outside the Greater Houston Area) | Complimentary |
| Research Scientist | Complimentary |
| Allied Health Care Professional / All Others | Complimentary |
| Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Physician scientists, practicing oncologists, physician assistants, advanced nurse practitioners, oncology nurses, residents, fellows, medical students, allied health care professionals and clinical research associates will benefit from this course.
Learning Objectives
At the conclusion of this activity, the learner should be able to:
Describe the pathogenesis of hepatobiliary cancers and the latest surveillance modalities.
Review the latest updates on transplant-bridging approaches, operative strategies for early-stage hepatobiliary cancers, and advancements in immunotherapy for both resectable and advanced hepatocellular carcinoma.
Explain the latest developments in molecular diagnostics, operative and perioperative approaches, and targeted therapies for pancreatic adenocarcinoma and neuroendocrine carcinoma.
TIME | PRESENTATION |
7:40 AM –8:00 AM | Registration |
8:00 AM –8:30 AM | Breakfast |
8:30 AM – 8:35 AM |
Welcome and Introduction |
8:35 AM –8:40 AM | Session 1A: Hepatobiliary Cancer |
8:40 AM –8:50 AM | Worldwide Epidemiology and United States Burden of Liver Cancers: Risk Factors and Prevention |
8:50 AM –9:00 AM | Pathogenesis and Surveillance Modalities of Hepatobiliary Cancer |
9:00 AM –9:10 AM | Current Status of Pre-Liver Cancer Diseases: Management and Future Directions |
9:10 AM –9:20 AM | Underuse and interventions of Hepatocellular Carcinoma screening and Blood-based HCC biomarkers |
09:20 AM –9:35 AM | Panel Discussion |
09:35 AM –09:40 AM | Session 1B: Hepatobiliary Cancer |
9:40 AM – 9:50 AM | Transplant-Bridging Approaches in Hepatocellular Carcinoma |
9:50 AM – 10:00 AM | New Frontiers for Immunotherapy in Patients with Advanced and Resectable Hepatocellular Carcinoma |
10:00 AM – 10:10 AM | Current and Emerging Management in Advanced Cholangiocarcinoma |
10:10 AM – 10:20 AM | Updates on Operative Approaches in Early-Stage Hepatobiliary Cancer |
10:20 AM – 10:30 AM | Transplant oncology for Hilar and Intrahepatic Cholangiocarcinoma: Updates and Future Directions |
10:30 AM –10:45 AM | Panel Discussion |
10:45 AM –10:50 AM | Session 2: Pancreatic & Neuroendocrine Cancer |
10:50 AM – 11:00 AM | Updates on Molecular Diagnostics |
11:00 AM – 11:10 AM | Updates on Operative and Perioperative Approaches in Pancreatic Adenocarcinoma |
11:10 AM – 11:20 AM | Targeted Therapy Developments in Advanced-Stage Pancreatic Adenocarcinoma |
11:20 AM – 11:30 AM | Updates in the Management of Low-/Intermediate-Grade Neuroendocrine Carcinoma |
11:30 AM – 11:45 AM
|
Panel Discussion |
11:45 AM – 12:15 PM | Keynote: Integrating Immunotherapy into the Neoadjuvant Space in Gastrointestinal Malignancies: A Shifting Paradigm |
12:15 PM – 12:20 PM |
Session 3: Colorectal Cancer |
12:20 PM – 12:30 PM | Updates in the Management of Colorectal Liver Metastases |
12:30 PM – 12:40 PM | Advancement in Surgical Management in Colorectal Cancer |
12:40 PM – 12:50 PM | Immunotherapy Developments in Colorectal Cancer, MSI-H |
12:50 PM –01:00 PM | Immunotherapy Developments in Colorectal Cancer, MSS |
01:00 PM – 01:10 PM | Precision Medicine Developments in Colorectal Cancer |
01:10 PM – 01:25 PM
|
Panel Discussion
|
01:25 PM – 02:25 PM | Networking Reception/Lunch |
02:25 PM – 02:030 PM |
Session 4: Esophageal and Gastric Cancer |
02:30 PM – 02:40 PM | Advances in Multidisciplinary Approaches in Resectable Gastric/Esophageal Cancer |
02:40 PM – 02:50 PM | Immunotherapy Advancements and Predictive Markers in Unresectable Gastroesophageal Adenocarcinoma |
02:50 PM – 03:00 PM | Precision Medicine Advancements in Unresectable Gastroesophageal Adenocarcinoma |
03:00 PM – 03:10 PM |
Panel Discussion |
03:10 PM – 03:15 PM | Concluding Remarks |
LIVE (in-person attendance) will be held in the Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030.
Virtual information will be provided to registered learners at a later date.
| CHAIR |
| Maen Abdelrahim, MD, PhD, B Pharm |
Section Chief of Gastrointestinal Medical Oncology |
Available Credit
- 5.25 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.25 Attendance
Interested in exhibiting or sponsoring? Contact us for more information.
Price
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Houston Methodist Employees | Complimentary |
| Physician (Private physician located within the Greater Houston Area)* | $170 |
| Physician (Private physician located outside the Greater Houston Area) | Complimentary |
| Research Scientist | Complimentary |
| Allied Health Care Professional / All Others | Complimentary |
| Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.